The post-2009 bull market in drug stocks is currently being threatened. In the midst of the selling pressure last week, we mentioned that several indices…
Tagged $PFE
Stock Buyback Binge Continues
Extension of ZIRP suggests company share repurchases will remain elevated…but will the correction have an effect? One contingent that was particularly happy to see the…
The Long & Short (Term) Of The Pharmaceutical Sector
We have written many times about the challenge of weighing positive vs.negative inputs when analyzing the attractiveness of the investment climate. Often times, that applies…